APA (7th ed.) Citation

M, A., R, T., M, H., KO, Y., A, S., MY, Z., . . . S, O. (2024). Safety and potential effects of intrathecal injection of allogeneic human umbilical cord mesenchymal stem cell-derived exosomes in complete subacute spinal cord injury: A first-in-human, single-arm, open-label, phase I clinical trial. Stem cell research & therapy, 15(1), 264. https://doi.org/10.1186/s13287-024-03868-0

Chicago Style (17th ed.) Citation

M, Akhlaghpasand, et al. "Safety and Potential Effects of Intrathecal Injection of Allogeneic Human Umbilical Cord Mesenchymal Stem Cell-derived Exosomes in Complete Subacute Spinal Cord Injury: A First-in-human, Single-arm, Open-label, Phase I Clinical Trial." Stem Cell Research & Therapy 15, no. 1 (2024): 264. https://doi.org/10.1186/s13287-024-03868-0.

MLA (9th ed.) Citation

M, Akhlaghpasand, et al. "Safety and Potential Effects of Intrathecal Injection of Allogeneic Human Umbilical Cord Mesenchymal Stem Cell-derived Exosomes in Complete Subacute Spinal Cord Injury: A First-in-human, Single-arm, Open-label, Phase I Clinical Trial." Stem Cell Research & Therapy, vol. 15, no. 1, 2024, p. 264, https://doi.org/10.1186/s13287-024-03868-0.